We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
23 hedge funds and large institutions have $67.9M invested in ADMA Biologics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $68M → $67.9M (-$130K)
12% less funds holding
Funds holding: 26 → 23 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
3
Increased
9
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$597K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$534K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28.7K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$24.5K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$24K |
Top Sellers
| 1 |
PC
PointState Capital
New York
|
-$1.64M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$130K |
| 3 |
Goldman Sachs
New York
|
-$107K |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$85.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$32K |
